Search Results - "Drouyer, Matthieu"
-
1
LRRK2 Phosphorylation, More Than an Epiphenomenon
Published in Frontiers in neuroscience (16-06-2020)“…Mutations in the Leucine Rich Repeat Kinase 2 (LRRK2) gene are linked to autosomal dominant Parkinson's disease (PD), and genetic variations at the LRRK2 locus…”
Get full text
Journal Article -
2
Protein phosphatase 2A holoenzymes regulate leucine-rich repeat kinase 2 phosphorylation and accumulation
Published in Neurobiology of disease (01-09-2021)“…LRRK2 is a highly phosphorylated multidomain protein and mutations in the gene encoding LRRK2 are a major genetic determinant of Parkinson's disease (PD)…”
Get full text
Journal Article -
3
Novel human liver-tropic AAV variants define transferable domains that markedly enhance the human tropism of AAV7 and AAV8
Published in Molecular therapy. Methods & clinical development (10-03-2022)“…Recent clinical successes have intensified interest in using adeno-associated virus (AAV) vectors for therapeutic gene delivery. The liver is a key clinical…”
Get full text
Journal Article -
4
PAK6-mediated phosphorylation of PPP2R2C regulates LRRK2-PP2A complex formation
Published in Frontiers in molecular neuroscience (18-12-2023)“…Mutations in leucine-rich repeat kinase 2 (LRRK2) are a common cause of inherited and sporadic Parkinson's disease (PD) and previous work suggests that…”
Get full text
Journal Article -
5
Attenuation of Heparan Sulfate Proteoglycan Binding Enhances In Vivo Transduction of Human Primary Hepatocytes with AAV2
Published in Molecular therapy. Methods & clinical development (12-06-2020)“…Use of the prototypical adeno-associated virus type 2 (AAV2) capsid delivered unexpectedly modest efficacy in an early liver-targeted gene therapy trial for…”
Get full text
Journal Article -
6
Novel AAV variants with improved tropism for human Schwann cells
Published in Molecular therapy. Methods & clinical development (13-06-2024)“…Gene therapies and associated technologies are transforming biomedical research and enabling novel therapeutic options for patients living with debilitating…”
Get full text
Journal Article -
7
Single amino acid insertion allows functional transduction of murine hepatocytes with human liver tropic AAV capsids
Published in Molecular therapy. Methods & clinical development (11-06-2021)“…Recent successes in clinical gene therapy applications have intensified the interest in using adeno-associated viruses (AAVs) as vectors for gene delivery into…”
Get full text
Journal Article -
8
A Phosphosite Mutant Approach on LRRK2 Links Phosphorylation and Dephosphorylation to Protective and Deleterious Markers, Respectively
Published in Cells (Basel, Switzerland) (17-03-2022)“…The ( ) gene is a major genetic determinant of Parkinson's disease (PD), encoding a homonymous multi-domain protein with two catalytic activities, GTPase and…”
Get full text
Journal Article -
9
Development of CNS tropic AAV1-like variants with reduced liver-targeting following systemic administration in mice
Published in Molecular therapy (06-03-2024)“…Directed evolution of natural AAV9 using peptide display libraries have been widely used in the search for an optimal recombinant AAV (rAAV) for transgene…”
Get more information
Journal Article -
10
GTP binding regulates cellular localization of Parkinson's disease-associated LRRK2
Published in Human molecular genetics (15-07-2017)“…Mutations in leucine-rich repeat kinase 2 (LRRK2) comprise the most common cause of familial Parkinson's disease (PD), and sequence variants modify risk for…”
Get full text
Journal Article -
11
LRRK2 detection in human biofluids: potential use as a Parkinson's disease biomarker?
Published in Biochemical Society transactions (08-02-2017)“…Leucine-rich repeat kinase 2 (LRRK2) is a complex signalling protein that is a key therapeutic target, particularly in Parkinson's disease (PD). In addition,…”
Get more information
Journal Article -
12
Enhanced AAV transduction across preclinical CNS models: A comparative study in human brain organoids with cross-species evaluations
Published in Molecular therapy. Nucleic acids (10-09-2024)“…Viral vectors based on recombinant adeno-associated virus (rAAV) have become the most widely used system for therapeutic gene delivery in the central nervous…”
Get full text
Journal Article -
13
Investigating the neuroprotective effect of AAV-mediated β-synuclein overexpression in a transgenic model of synucleinopathy
Published in Scientific reports (03-12-2018)“…Parkinson’s disease (PD) and multiple system atrophy (MSA) are neurodegenerative diseases characterized by inclusions mainly composed of α-synuclein (α-syn)…”
Get full text
Journal Article -
14
Phosphatome-wide siRNA screen reveals phosphorylation regulators of the Parkinson’s disease protein LRRK2
Published in Frontiers in neuroscience (2017)“…Abstract only…”
Get full text
Journal Article